96 related articles for article (PubMed ID: 17668873)
41. Biological activities of scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, Trichopeziza mollissima.
Nara F; Tanaka M; Masuda-Inoue S; Yamasato Y; Doi-Yoshioka H; Suzuki-Konagai K; Kumakura S; Ogita T
J Antibiot (Tokyo); 1999 Jun; 52(6):531-5. PubMed ID: 10470676
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of cytokine signaling in human retinal endothelial cells through downregulation of sphingomyelinases by docosahexaenoic acid.
Opreanu M; Lydic TA; Reid GE; McSorley KM; Esselman WJ; Busik JV
Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3253-63. PubMed ID: 20071681
[TBL] [Abstract][Full Text] [Related]
43. Sphingomyelinase treatment of rat hepatocytes inhibits cell-swelling-stimulated glycogen synthesis by causing cell shrinkage.
Van Sluijters DA; Van Woerkom GM; Aerts JM; Meijer AJ
Eur J Biochem; 1999 Dec; 266(2):653-9. PubMed ID: 10561609
[TBL] [Abstract][Full Text] [Related]
44. Synthesis and biochemical investigation of scyphostatin analogues as inhibitors of neutral sphingomyelinase.
Arenz C; Gartner M; Wascholowski V; Giannis A
Bioorg Med Chem; 2001 Nov; 9(11):2901-4. PubMed ID: 11597471
[TBL] [Abstract][Full Text] [Related]
45. 27-Hydroxycholesterol inhibits neutral sphingomyelinase in cultured human endothelial cells.
Zhou Q; Band MR; Hernandez A; Liu ZL; Kummerow FA
Life Sci; 2004 Aug; 75(13):1567-77. PubMed ID: 15261762
[TBL] [Abstract][Full Text] [Related]
46. The role of neutral sphingomyelinase in interleukin-1beta signal transduction in mouse cerebral cortex cells.
Rybakina EG; Nalivaeva NN; Pivanovich YU; Shanin SN; Kozinets A; Korneva EA
Neurosci Behav Physiol; 2001; 31(4):439-44. PubMed ID: 11508496
[TBL] [Abstract][Full Text] [Related]
47. Recovery of mature hepatocytic phenotype following bile ductular transdifferentiation of rat hepatocytes in vitro.
Sone M; Nishikawa Y; Nagahama Y; Kumagai E; Doi Y; Omori Y; Yoshioka T; Tokairin T; Yoshida M; Sugiyama T; Enomoto K
Am J Pathol; 2012 Dec; 181(6):2094-104. PubMed ID: 23041063
[TBL] [Abstract][Full Text] [Related]
48. Scyphostatin, a neutral sphingomyelinase inhibitor from a discomycete, Trichopeziza mollissima: taxonomy of the producing organism, fermentation, isolation, and physico-chemical properties.
Nara F; Tanaka M; Hosoya T; Suzuki-Konagai K; Ogita T
J Antibiot (Tokyo); 1999 Jun; 52(6):525-30. PubMed ID: 10470675
[TBL] [Abstract][Full Text] [Related]
49. Inhibition of neutral sphingomyelinase 2 reduces extracellular vesicle release from neurons, oligodendrocytes, and activated microglial cells following acute brain injury.
Tallon C; Picciolini S; Yoo SW; Thomas AG; Pal A; Alt J; Carlomagno C; Gualerzi A; Rais R; Haughey NJ; Bedoni M; Slusher BS
Biochem Pharmacol; 2021 Dec; 194():114796. PubMed ID: 34678224
[TBL] [Abstract][Full Text] [Related]
50. Nuclear localization of neutral sphingomyelinase 1: biochemical and immunocytochemical analyses.
Mizutani Y; Tamiya-Koizumi K; Nakamura N; Kobayashi M; Hirabayashi Y; Yoshida S
J Cell Sci; 2001 Oct; 114(Pt 20):3727-36. PubMed ID: 11707524
[TBL] [Abstract][Full Text] [Related]
51. Nitric oxide and interleukin-1β stimulate the proteasome-independent degradation of the retinoic acid hydroxylase CYP2C22 in primary rat hepatocytes.
Lee CM; Lee BS; Arnold SL; Isoherranen N; Morgan ET
J Pharmacol Exp Ther; 2014 Jan; 348(1):141-52. PubMed ID: 24144795
[TBL] [Abstract][Full Text] [Related]
52. Neutral sphingomyelinase-2 is a redox sensitive enzyme: role of catalytic cysteine residues in regulation of enzymatic activity through changes in oligomeric state.
Dotson PP; Karakashian AA; Nikolova-Karakashian MN
Biochem J; 2015 Feb; 465(3):371-82. PubMed ID: 25287744
[TBL] [Abstract][Full Text] [Related]
53. Critical determinants of mitochondria-associated neutral sphingomyelinase (MA-nSMase) for mitochondrial localization.
Rajagopalan V; Canals D; Luberto C; Snider J; Voelkel-Johnson C; Obeid LM; Hannun YA
Biochim Biophys Acta; 2015 Apr; 1850(4):628-39. PubMed ID: 25484313
[TBL] [Abstract][Full Text] [Related]
54. Targeting interleukin-1β for pain.
Pillarisetti S
CNS Neurol Disord Drug Targets; 2011 Aug; 10(5):571-5. PubMed ID: 21631409
[TBL] [Abstract][Full Text] [Related]
55. Effects of old age on hepatocyte oxygenation.
Cheluvappa R; Hilmer SN; Kwun SY; Cogger VC; LE Couteur DG
Ann N Y Acad Sci; 2007 Oct; 1114():88-92. PubMed ID: 17717093
[TBL] [Abstract][Full Text] [Related]
56. Studies toward the total synthesis of scyphostatin: first entry to the highly functionalized cyclohexenone segment.
Izuhara T; Katoh T
Org Lett; 2001 May; 3(11):1653-6. PubMed ID: 11405678
[TBL] [Abstract][Full Text] [Related]
57. A short and efficient route to novel scyphostatin analogues.
Runcie KA; Taylor RJ
Org Lett; 2001 Oct; 3(21):3237-9. PubMed ID: 11594803
[TBL] [Abstract][Full Text] [Related]
58. Onset of Senescence and Steatosis in Hepatocytes as a Consequence of a Shift in the Diacylglycerol/Ceramide Balance at the Plasma Membrane.
Deevska G; Dotson PP; Mitov M; Butterfield DA; Nikolova-Karakashian M
Cells; 2021 May; 10(6):. PubMed ID: 34064003
[TBL] [Abstract][Full Text] [Related]
59. Neutral Sphingomyelinase 2 Heightens Anti-Melanoma Immune Responses and Anti-PD-1 Therapy Efficacy.
Montfort A; Bertrand F; Rochotte J; Gilhodes J; Filleron T; Milhès J; Dufau C; Imbert C; Riond J; Tosolini M; Clarke CJ; Dufour F; Constantinescu AA; Junior NF; Garcia V; Record M; Cordelier P; Brousset P; Rochaix P; Silvente-Poirot S; Therville N; Andrieu-Abadie N; Levade T; Hannun YA; Benoist H; Meyer N; Micheau O; Colacios C; Ségui B
Cancer Immunol Res; 2021 May; 9(5):568-582. PubMed ID: 33727246
[TBL] [Abstract][Full Text] [Related]
60. Gene Expression Analysis of the Pre-Diabetic Pancreas to Identify Pathogenic Mechanisms and Biomarkers of Type 1 Diabetes.
Yip L; Fuhlbrigge R; Alkhataybeh R; Fathman CG
Front Endocrinol (Lausanne); 2020; 11():609271. PubMed ID: 33424774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
